Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines

被引:0
作者
Sevilay Batıbay
Rezan Koçak Ulucaköy
Zafer Günendi
Işıl Fidan
Gülendam Bozdayı
Feride Nur Göğüş
机构
[1] Gazi University Hospital,Division of Rheumatology, Department of Physical Medicine and Rehabilitation
[2] Ministry of Health Ankara City Hospital,Department of Internal Medicine, Division of Rheumatology
[3] Gazi University Hospital,Medical Microbiology
来源
Inflammopharmacology | 2022年 / 30卷
关键词
Covid-19; SARS-CoV-2; Vaccine; CoronaVac; BNT162b2; Rheumatology; Inflammatory rheumatic disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2089 / 2096
页数:7
相关论文
共 50 条
  • [31] Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines
    Atici, Serkan
    Soysal, Ahmet
    Gonullu, Erdem
    Aydemir, Gokhan
    Oner, Naci
    Alan, Servet
    Engin, Havva
    Yildiz, Melek
    Karabocuoglu, Metin
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2023, 56
  • [32] Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
    Milano, Eugenio
    Ricciardi, Aurelia
    Casciaro, Raffaella
    Pallara, Elisabetta
    De Vita, Elda
    Bavaro, Davide F.
    Larocca, Angela Maria Vittoria
    Stefanizzi, Pasquale
    Tafuri, Silvio
    Saracino, Annalisa
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 2230 - 2236
  • [33] Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Danylesko, Ivetta
    Litachevsky, Vladislav
    Levy, Itzchak
    Olmer, Liraz
    Lusitg, Yaniv
    Avigdor, Abraham
    Nagler, Arnon
    Shimoni, Avichai
    Rahav, Galia
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : 884 - 891
  • [34] Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
    Lotan, Itay
    Hellmann, Mark A.
    Friedman, Yitzhak
    Stiebel-Kalish, Hadas
    Steiner, Israel
    Wilf-Yarkoni, Adi
    NEUROMUSCULAR DISORDERS, 2022, 32 (03) : 230 - 235
  • [35] Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
    Amir Massarweh
    Roi Tschernichovsky
    Amos Stemmer
    Alexandra Benouaich-Amiel
    Tali Siegal
    Noa Eliakim-Raz
    Salomon M. Stemmer
    Shlomit Yust-Katz
    Journal of Neuro-Oncology, 2022, 156 : 483 - 489
  • [36] Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
    Hadjadj, Jerome
    Planas, Delphine
    Ouedrani, Amani
    Buffier, Solene
    Delage, Laure
    Nguyen, Yann
    Bruel, Timothee
    Stolzenberg, Marie-Claude
    Staropoli, Isabelle
    Ermak, Natalia
    Macraigne, Laure
    Morbieu, Caroline
    Henriquez, Soledad
    Veyer, David
    Pere, Helene
    Casadevall, Marion
    Mouthon, Luc
    Rieux-Laucat, Frederic
    Chatenoud, Lucienne
    Schwartz, Olivier
    Terrier, Benjamin
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 720 - 728
  • [37] Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study
    Massarweh, Amir
    Tschernichovsky, Roi
    Stemmer, Amos
    Benouaich-Amiel, Alexandra
    Siegal, Tali
    Eliakim-Raz, Noa
    Stemmer, Salomon M.
    Yust-Katz, Shlomit
    JOURNAL OF NEURO-ONCOLOGY, 2022, 156 (03) : 483 - 489
  • [38] Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease
    Ye, Xuxiao
    Ma, Tiantian
    Blais, Joseph E.
    Yan, Vincent K. C.
    Kang, Wei
    Chui, Celine S. L.
    Lai, Francisco T. T.
    Li, Xue
    Wan, Eric Y. F.
    Wong, Carlos K. H.
    Tse, Hung-Fat
    Siu, Chung-Wah
    Wong, Ian C. K.
    Chan, Esther W.
    CARDIOVASCULAR RESEARCH, 2022, 118 (10) : 2329 - 2338
  • [39] Antibody Response of Combination of BNT162b2 and CoronaVac Platforms of COVID-19 Vaccines against Omicron Variant
    Khong, Ka-Wa
    Liu, Danlei
    Leung, Ka-Yi
    Lu, Lu
    Lam, Hoi-Yan
    Chen, Linlei
    Chan, Pui-Chun
    Lam, Ho-Ming
    Xie, Xiaochun
    Zhang, Ruiqi
    Fan, Yujing
    To, Kelvin Kai-Wang
    Chen, Honglin
    Yuen, Kwok-Yung
    Chan, Kwok-Hung
    Hung, Ivan Fan-Ngai
    VACCINES, 2022, 10 (02)
  • [40] The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation
    Watanabe, Marika
    Yakushijin, Kimikazu
    Funakoshi, Yohei
    Ohji, Goh
    Hojo, Wataru
    Sakai, Hironori
    Saeki, Miki
    Hirakawa, Yuri
    Matsumoto, Sakuya
    Sakai, Rina
    Nagao, Shigeki
    Kitao, Akihito
    Miyata, Yoshiharu
    Koyama, Taiji
    Saito, Yasuyuki
    Kawamoto, Shinichiro
    Ito, Mitsuhiro
    Murayama, Tohru
    Matsuoka, Hiroshi
    Minami, Hironobu
    VACCINES, 2022, 10 (02)